Pyrrhocoricin as a potential drug delivery vehicle for Cryptosporidium parvum

Experimental Parasitology

Volumn 119, Issue 2, 2008, Pages 301-303

  Boxell, Annika ^a   Lee, Stephanie Hui Chin ^a   Jefferies, Ryan ^b   Watt, Paul ^b,c   Hopkins, Richard ^b,c   Reid, Simon ^a   Armson, Anthony ^a   Ryan, Una ^a  

^a MURDOCH UNIVERSITY   (Australia)

^b Discovery Technology   (Finland)

^c Phylogica Ltd   (Australia)

Author keywords

Cryptosporidium; Delivery vehicle; Peptides; Pyrrhocoricin

Indexed keywords

POLYPEPTIDE ANTIBIOTIC AGENT; PYRRHOCORICIN;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; CRYPTOSPORIDIUM PARVUM; DRUG DELIVERY SYSTEM; FLUORESCENCE MICROSCOPY; LIFE CYCLE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; ANTIPROTOZOAL AGENTS; CRYPTOSPORIDIUM PARVUM; DRUG CARRIERS; FLUORESCEIN; INSECT PROTEINS; MICROSCOPY, FLUORESCENCE; PEPTIDES;

CRYPTOSPORIDIUM; CRYPTOSPORIDIUM PARVUM; HEXAPODA;

EID: 42749084471     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2008.02.005     Document Type: Article

References (10)

1. Carey C.M., Lee H., and Trevors J.T. Biology, persistence and detection of Cryptosporidium parvum and Cryptosporidium hominis oocyst. Water Research 38 (2004) 818-862
2. Cociancich S., Dupont A., Hegy G., Lanot R., Holder F., Hetru C., Hoffmann J.A., and Bulet P. Novel inducible antibacterial peptides from a hemipteran insect, the sap-sucking bug Pyrrhocoris apterus. Biochemical Journal 300 (1994) 567-575
3. Cudic M., Lockatell C.V., Johnson D.E., and Otvos Jr. L. In vitro and in vivo activity of an antibacterial peptide analog against uropathogens. Peptides 24 (2003) 807-820
4. Fayer R. Cryptosporidium: a water-borne zoonotic parasite. Veterinary Parasitology 126 (2004) 37-56
5. Fayer R., Morgan U., and Upton S.J. Epidemiology of Cryptosporidium: transmission, detection and identification. International Journal for Parasitology 30 (2000) 1305-1322
6. Hijjawi N.S., Meloni B.P., Ng'anzo M., Ryan U.M., Olson M.E., Cox P.T., Monis P.T., and Thompson R.C. Complete development of Cryptosporidium parvum in host cell-free culture. International Journal for Parasitology 34 (2004) 769-777
7. Kragol G., Hoffmann R., Chattergoon M.A., Lovas S., Cudic M., Bulet P., Condie B.A., Rosengren K.J., Montaner L.J., and Otvos Jr. L. Identification of crucial residues for the antibacterial activity of the proline-rich peptide, pyrrhocoricin. European Journal for Biochemistry 269 (2002) 4226-4237
8. Puiu, D., Enomoto, S., Buck, G.A., Abrahamsen, M.S., Kissinger, J.C., 2004. CryptoDB: the Cryptosporidium genome resource. Nucleic Acids Research 32 (Database issue), D329-D331.
9. Striepen B., and Kissinger J.C. Genomics meets transgenics in search of the elusive Cryptosporidium drug target. Trends in Parasitology 20 (2004) 355-358
10. Watt P.M. Screening for peptide drugs from the natural repertoire of biodiverse protein folds. Nature Biotechnology 24 (2006) 177-183